Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

GAD antibody-associated neurological illness and its relationship to gluten sensitivity.

Hadjivassiliou M, Aeschlimann D, Grünewald RA, Sanders DS, Sharrack B, Woodroofe N.

Acta Neurol Scand. 2011 Mar;123(3):175-80. doi: 10.1111/j.1600-0404.2010.01356.x.

PMID:
20456245
[PubMed - indexed for MEDLINE]
2.
3.
4.

Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F.

Brain. 2008 Oct;131(Pt 10):2553-63. doi: 10.1093/brain/awn183. Epub 2008 Aug 7.

PMID:
18687732
[PubMed - indexed for MEDLINE]
Free Article
5.

Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.

Dalakas MC, Li M, Fujii M, Jacobowitz DM.

Neurology. 2001 Sep 11;57(5):780-4.

PMID:
11552003
[PubMed - indexed for MEDLINE]
6.

Transglutaminase 6 antibodies in the diagnosis of gluten ataxia.

Hadjivassiliou M, Aeschlimann P, Sanders DS, Mäki M, Kaukinen K, Grünewald RA, Bandmann O, Woodroofe N, Haddock G, Aeschlimann DP.

Neurology. 2013 May 7;80(19):1740-5. doi: 10.1212/WNL.0b013e3182919070. Epub 2013 Apr 10.

PMID:
23576621
[PubMed - indexed for MEDLINE]
7.

Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase.

Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D.

Ann Neurol. 2008 Sep;64(3):332-43. doi: 10.1002/ana.21450.

PMID:
18825674
[PubMed - indexed for MEDLINE]
8.

[Prevalence of diabetes-related autoantibodies in celiac disease].

Laadhar L, Ben Hariz M, Zitouni M, Sellami-Kallel M, Toumi A, Mehrezi A, Makni S.

Ann Endocrinol (Paris). 2006 Dec;67(6):588-90. French.

PMID:
17194969
[PubMed - indexed for MEDLINE]
9.

Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report.

Barera G, Bazzigaluppi E, Viscardi M, Renzetti F, Bianchi C, Chiumello G, Bosi E.

Pediatrics. 2001 Jun;107(6):E93.

PMID:
11389291
[PubMed - indexed for MEDLINE]
10.

Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.

Chang T, Alexopoulos H, McMenamin M, Carvajal-González A, Alexander SK, Deacon R, Erdelyi F, Szabó G, Lang B, Blaes F, Brown P, Vincent A.

JAMA Neurol. 2013 Sep 1;70(9):1140-9. Erratum in: JAMA Neurol. 2014 Feb;71(2):244. Gabor, Szabó [corrected to Szabó, Gabor].

PMID:
23877118
[PubMed - indexed for MEDLINE]
11.

[Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].

Schilling I, Conrad K, Füssel M, Henker J.

Dtsch Med Wochenschr. 2003 Jan 31;128(5):185-9. German.

PMID:
12557109
[PubMed - indexed for MEDLINE]
12.

Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia.

Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, Kandler RH, Lobo A, Powell T, Smith CM.

Lancet. 1998 Nov 14;352(9140):1582-5.

PMID:
9843103
[PubMed - indexed for MEDLINE]
13.

Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics.

Hadjivassiliou M, Grünewald R, Sharrack B, Sanders D, Lobo A, Williamson C, Woodroofe N, Wood N, Davies-Jones A.

Brain. 2003 Mar;126(Pt 3):685-91.

PMID:
12566288
[PubMed - indexed for MEDLINE]
Free Article
14.

Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.

Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F.

Neurology. 1997 Oct;49(4):1026-30.

PMID:
9339684
[PubMed - indexed for MEDLINE]
15.

Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects.

Hummel M, Bonifacio E, Naserke HE, Ziegler AG.

Diabetes Care. 2002 Jul;25(7):1111-6.

PMID:
12087006
[PubMed - indexed for MEDLINE]
16.
17.

Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes.

Takino H, Yamasaki H, Abiru N, Sera Y, Abe T, Kawasaki E, Yamaguchi Y, Eguchi K, Kanazawa Y, Nagataki S.

Diabet Med. 2002 Sep;19(9):730-4.

PMID:
12207808
[PubMed - indexed for MEDLINE]
18.

Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.

Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keränen T, Graus F.

Neurology. 2000 Jul 12;55(1):46-50.

PMID:
10891904
[PubMed - indexed for MEDLINE]
19.

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F.

Arch Neurol. 2001 Feb;58(2):225-30.

PMID:
11176960
[PubMed - indexed for MEDLINE]
20.

Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.

Bárová H, Perusicová J, Hill M, Sterzl I, Vondra K, Masek Z.

Physiol Res. 2004;53(3):279-86.

PMID:
15209535
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk